EULAR 2005

skip to the content

MabThera Rituximab – B Cell Therapy, Lasting Success

EULAR 2005 Media Kit

Media Briefing

B cells: a targeted approach to rheumatoid arthritis – agenda

Biography – Professor Emery

Biography – Professor van Vollenhoven

Press Release

Major study shows MabThera^®, an innovative B cell therapy, to be highly effective in treating rheumatoid arthritis

Backgrounders

About the DANCER study

Rheumatoid arthritis

Innovating the management of rheumatoid arthritis (RA) – understanding the role of B cells

Rituximab in rheumatoid arthritis

Rituximab in rheumatoid arthritis (RA) – milestones

Rituximab data sheet

Rituximab and rheumatoid arthritis images

Legal Statement
Sitemap
Privacy Policy
Roche.com
© 2009 F. Hoffmann-La Roche Ltd. The site is intended for non US physicians and scientific media only.Prescribing information, pricing and indications for MabThera may differ from country to country.Please consult your local Roche company for such information you may be interested in.